November 9, 2026
10 min read
January 19, 2024
11 min read
Updated November 20, 2026
Key takeaways
RPM use keeps growing: about 289,000 traditional Medicare patients received RPM in 2024, more than 20% more than in 2023, and the number of providers billing for it rose 12% to about 6,400.
Hypertension is RPM's biggest use case (55% of Medicare RPM patients), yet only about 15 in 1,000 Medicare enrollees used RPM in 2024, while about 62% of enrollees have hypertension.
RPM has strong clinical evidence support its use, especially for Hypertensive Medicare patients who saw rough 34% lower mortality risk and 22% lower hospitalization risk over six months while on RPM.
Remote patient monitoring (RPM) is one of the most effective forms of virtual care, and the latest RPM statistics show why. Around since the 1960s, it has steadily gained acceptance from practitioners, patients, payers, and the federal government, and its growth continued well past the COVID-19 pandemic.
As a valuable method for providing continuous care for patients throughout the COVID-19 pandemic, remote patient monitoring was thrust into the spotlight and helped practitioners forge effective paths for supporting patients and managing chronic disease from a distance. At the same time, RPM has generated favorable reimbursement and consistent revenue, which has proven tremendously valuable for a wide range of clinical applications.
Remote patient monitoring is a form of virtual technology that allows healthcare providers to monitor and electronically capture medical and other health data from patients for assessment, recommendations, and instructions. This data, which can include vital signs such as blood pressure, weight, heart rate, and blood sugar, can be collected anywhere the patient is, as long as they are not in a shared space with the provider delivering RPM services. This means a patient can be in their home, in an office, on vacation, in a skilled nursing facility, or any other location and benefit from RPM. For more in depth answers to who can receive RPM, visit our page on RPM Frequently asked questions.
RPM is being embraced by practices, patients and payers, and it is likely to play a growing role in healthcare delivery, something the statistics below, drawn from federal agencies, peer-reviewed journals and established policy trackers, demonstrate well.
About 1 in 5 U.S. physicians (20.3%) worked in a practice that used RPM in 2024, roughly double the 2018 share, and 42 state Medicaid programs now pay for it. Adoption is broad but far from saturated.
One in five physicians (20.3%) work in a practice that uses RPM as of 2024. That's about double the 2018 rate (10.4%), and it has held steady since 2020.
(Source: AMA Policy Research Perspectives, Nov 2025)
Physicians in hospital-owned practices (24.3%) are more likely to use RPM than those in private practice (16.9%), a 7-point gap.
(Source: AMA, Nov 2025)
Medical specialists use RPM most, at 29%–34% depending on practice ownership. Primary care physicians follow at 21%–25%.
(Source: AMA, Nov 2025)
More than half of physicians are in practices that use telehealth to manage chronic disease, up from 9.9% in 2018.
(Source: AMA, Nov 2025)
As of Fall 2026, 42 state Medicaid programs reimburse RPM; five of them limit payment to specific CTBS codes. Recent expansions include Maryland (any condition, no prior authorization) and California (age 21+ limit removed).
(Source: Center for Connected Health Policy, Fall 2026)
The global RPM market is estimated at $36.3 billion in 2026 and projected to reach $66.3 billion by 2031 (12.8% CAGR). North America held 53.3% of the market in 2025.
(Source: MarketsandMarkets, May 2026)
The U.S. RPM market was valued at $16.1 billion in 2025 and is projected to reach $29.1 billion by 2030 (12.6% CAGR).
(Source: MarketsandMarkets, Feb 2026)
By 2027, the total number of patients using RPM solutions is expected to reach 115.5 million globally.
(Source: Juniper Research)
About 289,000 Medicare patients received remote patient monitoring in 2024, more than 20% more than in 2023, and the number of providers billing for it rose 12% to about 6,400, according to the latest CMS data. The statistics below show how fast that use has grown, which specialties and states are driving it, and what it means for the practices that adopt RPM.
(Source: Prevounce)
20% of large healthcare facilities surveyed said they have already adopted some sort of RPM solution for their organization.
(Source: HealthTech Insider)
Across 25 surveyed organizations, admissions for chronic care complications were reduced between 19% percent and 41% thanks to RPM.
(Source: Strategic Market Research)
Throughout both urban and rural areas, 75% of doctors have adopted some type of remote patient monitoring to manage chronic health conditions.
(Source: Strategic Market Research)
Primary care practices that began billing RPM between 2019 and 2021 grew Medicare revenue 20% relative to matched non-adopters. About a quarter of the gain came from added care management and outpatient visits, not RPM billing alone.
(Source: Tang et al., Health Affairs, Nov 2025)
The same practices saw 2.9% more patients each quarter and completed 4.3% more outpatient visits, without reducing access for patients not on RPM.
(Source: Tang et al. via AJMC, Nov 2025)
Primary care clinicians delivered nearly half (48%) of Medicare RPM services from 2019 to 2023; medical subspecialists such as cardiologists delivered 38%.
(Source: Health Affairs Scholar, June 2025)
RPM use among medical subspecialists grew 4,819% from 2019 to 2023, outpacing primary care's 3,035% growth.
(Source: Health Affairs Scholar, June 2025)
Hypertension is RPM's leading use case. While about 62% of enrollees have hypertension only 15 in every 1,000 Medicare enrollees used RPM in 2024, leaving most eligible patients unreached.
(Source: HHS-OIG, Sept 2024)
Yes, RPM has extensive clinical data showing improved outcomes for hypertension, heart failure and type 2 diabetes, and many of the conditions most RPM programs treat. Patients enrolled in care management with Prevounce's care team saw substantial reductions in blood pressure, with the average systolic decreasing by 6.3% and diastolic by 7.4% at nine months with, stage 2 patients seeing the largest reductions of 9.1% and 9.7% respectively.
Among 16,339 Medicare RPM users with hypertension matched to 63,333 non-users, 180-day mortality was 2.9% vs 4.3%.
(Source: J Gen Intern Med, 2024)
In the same study, RPM users had a 22% lower hazard of any hospitalization over 180 days (hazard ratio 0.78).
(Source: J Gen Intern Med, 2024)
Stage 2 hypertensive patients in an RPM program with ongoing care management saw a 9.1% reduction in systolic and 9.7% reduction in diastolic blood pressure.
(Source: Prevounce outcomes analysis, 2026)
Home telemonitoring for heart failure cut all-cause mortality by 16% and first heart failure hospitalizations by 19% versus standard care, in a meta-analysis of randomized trials. Total HF hospitalizations fell 15%.
(Source: Scholte et al., European Heart Journal, 2023)
Home telemonitoring lowered HbA1c by 0.42 percentage points across 20 randomized trials of adults with type 2 diabetes (median 180 days).
(Source: Meta-analysis, PMC)
By delivering 20 minutes of remote patient monitoring per month, each Medicare beneficiary can generate reimbursement of more than $1,000 over a 12-month period.
(Source: Prevounce)
Most patients are comfortable monitoring at home: 79% of U.S. consumers in a 2025 representative survey said so, and 84% prefer home monitoring if the devices are reliable. Physicians are on board too: 53% say they are enthusiastic about remote monitoring devices.
79% of U.S. consumers are comfortable using medical devices at home for routine tests like blood pressure and glucose; under 10% are uncomfortable.
(Source: TechTarget, Oct 2025)
84% would prefer to monitor their health at home if the technology is reliable and accurate.
(Source: TechTarget, Oct 2025)
63% believe RPM can provide the same level of care as in-clinic visits for certain conditions; 12% disagree.
(Source: TechTarget, Oct 2025)
87% of cardiac patients would be more likely to join a home monitoring program if insurance covers it, and 60% would not pay out of pocket. 63% rank automatic data transmission as the top ease-of-use factor.
(Source: Vivalink survey of 150+ U.S. adults with cardiac conditions, via DAIC, Sept 2026)
Private-practice physicians cite implementation cost about twice as often as hospital-owned peers (14.9% vs 7.2%).
(Source: AMA, Nov 2025)
Remote monitoring devices rank second only to virtual visits in physician enthusiasm (53%), and physician use of remote monitoring devices more than doubled from 12% in 2016 to 30% in 2022.
(Source: AMA Digital Health Research, Sept 2022)
References:
Acharya, M., et al. (2024). Association of remote patient monitoring with mortality and healthcare utilization in hypertensive patients: A Medicare claims-based study. Journal of General Internal Medicine, 39(5), 762–773. https://pubmed.ncbi.nlm.nih.gov/37973707/
AJMC. (2025, November 4). Remote physiological monitoring improves patient access, care, and revenue. The American Journal of Managed Care. https://www.ajmc.com/view/remote-patient-monitoring-improves-patient-access-care-and-revenue
American Medical Association. (2022, September 13). AMA: Physicians propelling health care’s digital transformation [Press release]. https://www.ama-assn.org/press-center/ama-press-releases/ama-physicians-propelling-health-care-s-digital-transformation
Center for Connected Health Policy. (2025). State telehealth laws and reimbursement policies report, Fall 2025. https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025
Centers for Medicare & Medicaid Services. (2024). CMS financial report: Fiscal year 2024. https://cms.gov/files/document/cms-financial-report-fiscal-year-2024.pdf
Diagnostic and Interventional Cardiology. (2026, October 1). Survey: Patients want home-based cardiac rehab, but coverage, clinical oversight drive participation. DAIC. https://www.dicardiology.com/node/85545
Home telemonitoring of patients with type 2 diabetes: A meta-analysis and systematic review. (n.d.). PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC8914593
Joo, J. H., Lieu, N., Tang, Y., Browne, D. S., Agusala, B., & Liao, J. M. (2025). Trends in utilization of remote monitoring in the United States. Health Affairs Scholar, 3(6), qxaf115. https://academic.oup.com/healthaffairsscholar/article/3/6/qxaf115/8157557
Juniper Research. (2023, January 16). Remote patient monitoring users to reach 115 million globally by 2027 [Press release]. https://www.juniperresearch.com/press/remote-patient-monitoring-users-reach-115m-2027/
Kane, C. K. (2025, November). Patient-facing telehealth: Use is higher than pre-pandemic but with great variation across physician specialties. American Medical Association Policy Research Perspectives. https://www.ama-assn.org/system/files/2024-prp-telehealth.pdf
MarketsandMarkets. (2026, February 19). US remote patient monitoring (RPM) market [Press release]. https://www.marketsandmarkets.com/PressReleases/us-remote-patient-monitoring-rpm.asp
MarketsandMarkets. (2026, May 28). Remote patient monitoring (RPM) market worth $66.33 billion by 2031 [Press release]. PR Newswire. https://www.prnewswire.com/news-releases/remote-patient-monitoring-rpm-market-worth-66-33-billion-by-2031--marketsandmarkets-302784256.html
McCarron, I. (2026, June 29). What the latest CMS data say about remote care: 5 trends in RPM and CCM adoption. Prevounce Blog. https://blog.prevounce.com/what-the-latest-cms-data-say-about-remote-care-5-trends-in-rpm-and-ccm-adoption
Prevounce Health. (n.d.). Remote patient monitoring software. https://www.prevounce.com/software/remote-patient-monitoring
Prevounce Health. (2026). Prevounce analysis finds RPM delivers significant, sustained blood pressure reductions [Press release]. https://blog.prevounce.com/newsroom/prevounce-analysis-finds-rpm-delivers-significant-sustained-blood-pressure-reductions
Remote patient monitoring to be mainstream in 5 years. (2021, March 12). Health Tech Insider. https://healthtechinsider.com/2021/03/12/remote-patient-monitoring-to-be-mainstream-in-5-years/
Scholte, N. T. B., et al. (2023). Telemonitoring for heart failure: A meta-analysis. European Heart Journal, 44(31), 2911–2926. https://pmc.ncbi.nlm.nih.gov/articles/PMC10424885/
Strategic Market Research. (2023, July). Global remote patient monitoring statistics 2023: Facts & figures. https://www.strategicmarketresearch.com/blogs/remote-patient-monitoring-statistics
Tang, M., Stern, A. D., Marcondes, F., & Mehrotra, A. (2025). Practices that adopted remote physiologic monitoring increased Medicare revenue and outpatient visits. Health Affairs, 44(11), 1386–1394. https://doi.org/10.1377/hlthaff.2025.00683
U.S. Department of Health and Human Services, Office of Inspector General. (2024, September). Additional oversight of remote patient monitoring in Medicare is needed (OEI-02-23-00260). https://oig.hhs.gov/reports/all/2024/additional-oversight-of-remote-patient-monitoring-in-medicare-is-needed
U.S. Department of Health and Human Services, Office of Inspector General. (2025, August). Billing for remote patient monitoring in Medicare (OEI-02-23-00261). https://oig.hhs.gov/reports/all/2025/billing-for-remote-patient-monitoring
Vaidya, A. (2025, October 29). Survey: At-home monitoring devices popular, affordable. TechTarget. https://www.techtarget.com/virtualhealthcare/news/366633680/Survey-At-home-monitoring-devices-popular-affordable
Lucy Lamboley is the Vice President of Operations of Prevounce. She oversees Prevounce's care management, customer success, and logistics functions. Through prior experience managing a primary care practice in Georgia, she developed deep expertise in office administration, clinical workflows, and billing best practices. In this role, she oversaw the launch and growth of the practice's successful chronic care management program. She is passionate about improving operational efficiency and empowering clinicians and staff to operate at the top of their licenses.